{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:39:55Z","timestamp":1784957995637,"version":"3.55.0"},"publisher-location":"Cham","reference-count":34,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032228994","type":"print"},{"value":"9783032229007","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/164_2025_782","type":"book-chapter","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:02:47Z","timestamp":1767027767000},"page":"39-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Laboratory and Point of Care Monitoring of Vitamin K Antagonist Treatment"],"prefix":"10.1007","author":[{"given":"Ian","family":"Jennings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"2 Suppl","key":"782_CR1","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G (2012) Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e44S\u2013e88S","journal-title":"Chest"},{"issue":"6 Suppl","key":"782_CR2","doi-asserted-by":"publisher","first-page":"160S","DOI":"10.1378\/chest.08-0670","volume":"133","author":"J Ansell","year":"2008","unstructured":"Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):160S\u2013198S","journal-title":"Chest"},{"issue":"6","key":"782_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.1958.02990230030005","volume":"167","author":"S Baer","year":"1958","unstructured":"Baer S, Yarrow MW, Kravitz C, Markson V (1958) Clinical experiences with warfarin (coumadin) sodium as an anticoagulant. JAMA J Am Med Assoc 167(6):704\u2013708","journal-title":"JAMA J Am Med Assoc"},{"key":"782_CR4","first-page":"1041","volume":"105","author":"e Bailey","year":"1971","unstructured":"Bailey e, Harper A, Pinkerton PH (1971) The \u201ctherapeutic range\u201d of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations. CMAJ 105:1041","journal-title":"CMAJ"},{"issue":"2","key":"782_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0037-1615184","volume":"80","author":"V Chantarangkul","year":"1998","unstructured":"Chantarangkul V, Tripodi A, Clerici M, Negri B, Mannucci PM (1998) Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations. Thromb Haemost 80(2):258\u2013262","journal-title":"Thromb Haemost"},{"key":"782_CR6","volume-title":"Procedures for validation of INR and local calibration","author":"CLSI","year":"2005","unstructured":"CLSI (2005) Procedures for validation of INR and local calibration, 1st edn. CLSI H54-A","edition":"1"},{"issue":"2","key":"782_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/fampra\/15.2.144","volume":"15","author":"DA Fitzmaurice","year":"1998","unstructured":"Fitzmaurice DA, Hobbs FD, Murray ET (1998) Primary care anticoagulant clinic management using computerized decision support and near patient International Normalized Ratio (INR) testing: routine data from a practice nurse-led clinic. Fam Pract 15(2):144\u2013146","journal-title":"Fam Pract"},{"issue":"3","key":"782_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/ijlh.14051","volume":"45","author":"DA Fitzmaurice","year":"2023","unstructured":"Fitzmaurice DA, Geersing GJ, Armoiry X, Machin S, Kitchen S, Mackie I (2023) ICSH guidance for INR and D-dimer testing using point of care testing in primary care. Int J Lab Hematol 45(3):276\u2013281","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"782_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/s-0038-1665293","volume":"50","author":"J Hermans","year":"1983","unstructured":"Hermans J, van den Besselaar AM, Loeliger EA, van der Velde EA (1983) A collaborative calibration study of reference materials for thromboplastins. Thromb Haemost 50(3):712\u2013717","journal-title":"Thromb Haemost"},{"issue":"3","key":"782_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-2003-44463","volume":"3","author":"EM Hylek","year":"2003","unstructured":"Hylek EM (2003) Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors. Semin Vasc Med 3(3):271\u2013278","journal-title":"Semin Vasc Med"},{"issue":"11","key":"782_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa022913","volume":"349","author":"EM Hylek","year":"2003","unstructured":"Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349(11):1019\u20131026","journal-title":"N Engl J Med"},{"issue":"5","key":"782_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/bjh.13070","volume":"167","author":"I Jennings","year":"2014","unstructured":"Jennings I, Kitchen D, Keeling D, Fitzmaurice D, Heneghan C, BCSH Committee (2014) Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology. Br J Haematol 167(5):600\u2013607","journal-title":"Br J Haematol"},{"issue":"4","key":"782_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/ijlh.12318","volume":"37","author":"I Jennings","year":"2015","unstructured":"Jennings I, Kitchen DP, Woods TA, Kitchen S, Preston FE, Walker ID (2015) Stability of coagulation proteins in lyophilized plasma. Int J Lab Hematol 37(4):495\u2013502","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"782_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/ijlh.12918","volume":"41","author":"I Jennings","year":"2019","unstructured":"Jennings I, Kitchen D, Kitchen S, Woods T, Walker I (2019) The importance of commutability in material used for quality control purposes. Int J Lab Hematol 41(1):39\u201345","journal-title":"Int J Lab Hematol"},{"key":"782_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2141.2011.08753.x","volume":"154","author":"D Keeling","year":"2011","unstructured":"Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, Kitchen S, Makris M, British Committee for Standards in Haematology (2011) Guidelines on oral anticoagulation with warfarin \u2013 fourth edition. Br J Haematol 154:311\u2013324","journal-title":"Br J Haematol"},{"issue":"2","key":"782_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2141.2005.05610.x","volume":"130","author":"DP Kitchen","year":"2005","unstructured":"Kitchen DP, Kitchen S, Jennings I, Woods TA, Walker ID, Preston FE (2005) Point of care testing by health care professionals: current practice amongst the UK National External Quality Assessment Scheme Participants. Br J Haematol 130(2):320\u2013321","journal-title":"Br J Haematol"},{"issue":"7","key":"782_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1055\/s-0028-1104543","volume":"34","author":"DP Kitchen","year":"2008","unstructured":"Kitchen DP, Kitchen S, Jennings I, Woods T, Walker I (2008) Quality assessment in point-of-care coagulation testing. Semin Thromb Hemost 34(7):647\u2013653","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"782_CR18","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/jclinpath-2012-201049","volume":"65","author":"DP Kitchen","year":"2012","unstructured":"Kitchen DP, Kitchen S, Jennings I, Woods TA, Fitzmaurice DA, Murray ET, Walker ID (2012) Point of Care INR testing devices: performance of the Roche CoaguChek XS and XS Plus in the UK NEQAS BC external quality assessment programme for healthcare professionals: four years\u2019 experience. J Clin Pathol 65(12):1119\u20131123","journal-title":"J Clin Pathol"},{"issue":"3","key":"782_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/s-0035-1544197","volume":"41","author":"DP Kitchen","year":"2015","unstructured":"Kitchen DP, Jennings I, Kitchen S, Woods TA, Walker ID (2015) Bridging the gap between point-of-care testing and laboratory testing in hemostasis. Semin Thromb Hemost 41(3):272\u2013278","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"782_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/ijlh.13795","volume":"44","author":"S Kitchen","year":"2022","unstructured":"Kitchen S, Bowyer A, Lowe A, Jennings I, Walker ID (2022) External quality assessment for one-stage and chromogenic factor IX assays in samples containing Alprolix (rFIXFc) or Idelvion (rIX-FP) and evidence that UK National External Quality Assessment Scheme for blood coagulation samples are commutable with patient samples. Int J Lab Hematol 44(3):619\u2013625","journal-title":"Int J Lab Hematol"},{"issue":"12","key":"782_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/milmed\/163.12.820","volume":"163","author":"SD Koerner","year":"1998","unstructured":"Koerner SD, Fuller RE (1998) Comparison of a portable capillary whole blood coagulation monitor and standard laboratory methods for determining international normalized ratio. Mil Med 163(12):820\u2013825","journal-title":"Mil Med"},{"issue":"1","key":"782_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2141.1990.00122.x-i1","volume":"74","author":"S Kumar","year":"1990","unstructured":"Kumar S, Haigh JR, Tate G, Boothby M, Joanes DN, Davies JA, Roberts BE, Feely MP (1990) Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance. Br J Haematol 74(1):82\u201385","journal-title":"Br J Haematol"},{"issue":"4","key":"782_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00133081","volume":"3","author":"KE Leaning","year":"1996","unstructured":"Leaning KE, Ansell JE (1996) Advances in the monitoring of oral anticoagulation: point-of-care testing, patient self-monitoring, and patient self-management. J Thromb Thrombolysis 3(4):377\u2013383","journal-title":"J Thromb Thrombolysis"},{"key":"782_CR24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/202498a0","volume":"202","author":"RG Macfarlane","year":"1964","unstructured":"Macfarlane RG (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498\u2013499","journal-title":"Nature"},{"issue":"11","key":"782_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/jcp.52.11.842","volume":"52","author":"ET Murray","year":"1999","unstructured":"Murray ET, Fitzmaurice DA, Allan TF, Hobbs FD (1999) A primary care evaluation of three near patient coagulometers. J Clin Pathol 52(11):842\u2013845","journal-title":"J Clin Pathol"},{"issue":"5","key":"782_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/000331975700800508","volume":"8","author":"JH Nicholson","year":"1957","unstructured":"Nicholson JH (1957) Clinical experiences with anticoagulants; a comparison of coumadin (warfarin) sodium and dicumarol (bishydroxycoumarin). Angiology 8(5):456\u2013465","journal-title":"Angiology"},{"issue":"1","key":"782_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0002-8703(58)90256-4","volume":"55","author":"CM Shapiro","year":"1958","unstructured":"Shapiro CM, Lisker R, Lichtman AM, Josephson AM (1958) Comparative clinical study of coumadin sodium and dicumarol in patients with thromboembolic diseases. Am Heart J 55(1):66\u201372","journal-title":"Am Heart J"},{"key":"782_CR28","first-page":"214","volume":"46","author":"SR Townsend","year":"1942","unstructured":"Townsend SR, Mills ES (1942) Effect of synthetic haemorrhagic agent 3,3\u2032-methylene-bis (4-hydroxycoumarin) in prolonging coagulation and prothrombin time in human subject. Canad MAJ 46:214","journal-title":"Canad MAJ"},{"issue":"4","key":"782_CR29","first-page":"271","volume":"15","author":"AM van den Besselaar","year":"1985","unstructured":"van den Besselaar AM (1985) Standardization of the prothrombin time in oral anticoagulant control. Haemostasis 15(4):271\u2013277","journal-title":"Haemostasis"},{"issue":"11","key":"782_CR30","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/j.1538-7836.2004.00970.x","volume":"2","author":"AM van den Besselaar","year":"2004","unstructured":"van den Besselaar AM, Barrowcliffe TW, Houbouyan-R\u00e9veillard LL, Jespersen J, Johnston M, Poller L, Tripodi A, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the ISTH (2004) Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost 2(11):1946\u20131953","journal-title":"J Thromb Haemost"},{"issue":"11","key":"782_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1136\/jclinpath-2012-200934","volume":"65","author":"AM van den Besselaar","year":"2012","unstructured":"van den Besselaar AM, P\u00e9qu\u00e9riaux NC, Ebben M, van der Feest J, de Jong K, Ganzeboom MB, van Ooijen J, Postema F, Witteveen E, van der Meer FJ (2012) Point-of-care monitoring of vitamin K-antagonists: validation of CoaguChek XS test strips with International Standard thromboplastin. J Clin Pathol 65(11):1031\u20131035","journal-title":"J Clin Pathol"},{"issue":"1","key":"782_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jth.13879","volume":"16","author":"AMHP van den Besselaar","year":"2018","unstructured":"van den Besselaar AMHP, Chantarangkul V, Angeloni F, Binder NB, Byrne M, Dauer R, Gudmundsdottir BR, Jespersen J, Kitchen S, Legnani C, Lindahl TL, Manning RA, Martinuzzo M, Panes O, Pengo V, Riddell A, Subramanian S, Szederjesi A, Tantanate C, Herbel P, Tripodi A (2018) International collaborative study for the calibration of proposed international standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain. J Thromb Haemost 16(1):142\u2013149","journal-title":"J Thromb Haemost"},{"issue":"4","key":"782_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jtha.2023.12.013","volume":"22","author":"AMHP van den Besselaar","year":"2024","unstructured":"van den Besselaar AMHP, Stavelin A, Kitchen S, Bryant M, Tripodi A, Scalambrino E, Clerici M, Herbel P, J\u00fcnschke A, Meyer Dos Santos S, Meijer P, Niessen RWLM, Meijers JCM, Thelwell C, Cuker A, Kung C, Cao Z, Zander N, Iwasaki Y, Depasse F, van Rijn C, Baktawar S, Abdoel C, Cobbaert CM (2024) Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC\/ISTH working group on prothrombin time\/international normalized ratio standardization. J Thromb Haemost. 22(4):1236\u20131248","journal-title":"J Thromb Haemost."},{"issue":"18","key":"782_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0025-6196(26)02361-X","volume":"28","author":"JM Wolff","year":"1953","unstructured":"Wolff JM, Barker NW, Gifford RW Jr, Mann FD (1953) Experience with a new intravenous coumarin anticoagulant (warfarin, sodium derivative). Proc Staff Meet Mayo Clin 28(18):489\u2013497","journal-title":"Proc Staff Meet Mayo Clin"}],"container-title":["Handbook of Experimental Pharmacology","Antithrombotic and Antiplatelet Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2025_782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:42:08Z","timestamp":1777056128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2025_782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783032228994","9783032229007"],"references-count":34,"URL":"https:\/\/doi.org\/10.1007\/164_2025_782","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"30 December 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}